Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine alone versus duloxetine + bupropion in fibromyalgia
IRCT20260819070731N1Phase 3Recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in fibromyalgia (FM) comparing Duloxetine + bupropion with Duloxetine alone (2 arms). Primary endpoints: Hospital Anxiety and Depression Scale, Metamemory Questionnaire and 1 more. Started Sep 2026; status: recruiting.
02
Drugs
duloxetinebupropion
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on IRCT20260819070731N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260819070731N1.